cefuroxime has been researched along with Infections, Staphylococcal in 81 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Excerpt | Relevance | Reference |
---|---|---|
"Our objective was to examine whether empirical antimicrobial therapy (EAT) against methicillin-susceptible Staphylococcus aureus bacteremia (MS-SAB) with piperacillin-tazobactam (TZP), cefuroxime or combination therapy with one of these was differentially associated with 7-, 30-, and 90- day all-cause mortality or MS-SAB relapse." | 8.12 | Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia. ( Benfield, T; Bigseth, RS; Petersen, A; Sandholdt, H; Thorlacius-Ussing, L; Østergaard, C, 2022) |
"To present the outcomes of prophylaxis of postoperative endophthalmitis following cataract surgery with intracameral Cefuroxime." | 7.75 | [Prophylaxis of postoperative endophthalmitis with intracameral cefuroxime: a five years' experience]. ( Arteta, M; De la Rosa, G; Díez, MR; Girón, C; Pascual, R, 2009) |
" The efficacy of netilmycin and vancomycin as combined first line antimicrobial regime, compared to cefuroxime, in the treatment of peritonitis." | 7.68 | Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients. ( Gokal, R; Marsden, A; Mistry, CD; Ramsden, R; Tooth, A; Were, AJ, 1992) |
" administration of aztreonam (A) and cefuroxime (C), 10 adult CAPD patients (pts) with peritonitis were trained to start the following treatment procedure: a) sterile collection of dialysate effluent for cultures; b) 4 rapid in-and-out exchanges with antibiotic free dialysate; c) addition of 2 g C and 2 g A to a 2-L exchange for 6-h dwell time (the same dosage was repeated once a day in the overnight exchange); d) routine CAPD exchanges." | 5.28 | Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD). ( Conte, G; Fuiano, G; Nani, E; Sepe, V; Viscione, M, 1989) |
"Our objective was to examine whether empirical antimicrobial therapy (EAT) against methicillin-susceptible Staphylococcus aureus bacteremia (MS-SAB) with piperacillin-tazobactam (TZP), cefuroxime or combination therapy with one of these was differentially associated with 7-, 30-, and 90- day all-cause mortality or MS-SAB relapse." | 4.12 | Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia. ( Benfield, T; Bigseth, RS; Petersen, A; Sandholdt, H; Thorlacius-Ussing, L; Østergaard, C, 2022) |
"To present the outcomes of prophylaxis of postoperative endophthalmitis following cataract surgery with intracameral Cefuroxime." | 3.75 | [Prophylaxis of postoperative endophthalmitis with intracameral cefuroxime: a five years' experience]. ( Arteta, M; De la Rosa, G; Díez, MR; Girón, C; Pascual, R, 2009) |
"We report the successful treatment of an abscess in the corpus cavernosum of a paraplegic man on intracavernous papaverine injection therapy by means of percutaneous aspiration and intravenous antibiotics." | 3.68 | Treatment of corpus cavernosum abscess by aspiration and intravenous antibiotics. ( de la Fuente, RB; Kropman, RF; van Imhoff, WL; Venema, PL, 1993) |
" The efficacy of netilmycin and vancomycin as combined first line antimicrobial regime, compared to cefuroxime, in the treatment of peritonitis." | 3.68 | Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients. ( Gokal, R; Marsden, A; Mistry, CD; Ramsden, R; Tooth, A; Were, AJ, 1992) |
"Cefuroxime was administered as a 1." | 2.67 | Cefuroxime versus cefazolin as prophylaxis in vascular surgery. ( Appleby, TC; Edwards, WH; Kaiser, AB; Kernodle, DS; Martin, RS; Mulherin, JL; Wood, CA, 1992) |
"Standard once-daily dosing of ceftriaxone may not lead to adequate antibiotic exposure in all cases of Staphylococcus aureus bacteraemia (SAB)." | 1.91 | Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study. ( Bonten, MJM; Buis, DTP; Herpers, BL; Jansen, RR; Prins, JM; Rozemeijer, W; Sieswerda, E; Sigaloff, KCE; Soetekouw, R; van der Meer, JTM; van der Vaart, TW; van Twillert, G; van Werkhoven, CH; Veenstra, J, 2023) |
"Cefuroxime was administered intravenously as a bolus according to weight (20 mg/kg)." | 1.72 | Weight-based cefuroxime dosing provides comparable orthopedic target tissue concentrations between weight groups - a microdialysis porcine study. ( Bue, M; Falstie-Jensen, T; Hanberg, P; Knudsen, MB; Schmedes, AV; Stilling, M; Thillemann, TM; Tøstesen, SK; Tøttrup, M, 2022) |
"Cefuroxime was administered in a weight-adjusted dosage equivalent to human medicine (18." | 1.48 | Antibiotic Prophylaxis With Cefuroxime: Influence of Duration on Infection Rate With Staphylococcus aureus in a Contaminated Open Fracture Model. ( Arens, D; Kuehl, R; Metsemakers, WJ; Moriarty, TF; Puetzler, J; Raschke, MJ; Richards, RG; Zeiter, S, 2018) |
"Ciprofloxacin tablet is a dominant option and much more cost-effective than either cefuroxime or gentamicin in the treatment of S." | 1.38 | Cost effectiveness of three drugs for the treatment of S. aureus infections in Nigeria. ( Bamiro, BS; Suleiman, IA; Tayo, F, 2012) |
"Although pyomyositis is a rare disease, it should be considered in the differential diagnosis of immediate onset of musculoskeletal pain in children." | 1.35 | Pyomyositis in children: early diagnosis and treatment. ( Berisa, AE; Georgoulis, AD; Lykissas, MG; Manoudis, GN; Mitsionis, GI; Motsis, E; Sionti, I, 2009) |
"Cases of bacterial meningitis during 1984-1999 in the County of North Jutland, Denmark (approx." | 1.32 | Staphylococcus aureus meningitis: experience with cefuroxime treatment during a 16 year period in a Danish region. ( Gudmundsdottir, G; Larsen, CS; Nørgaard, M; Schønheyder, HC, 2003) |
" administration of aztreonam (A) and cefuroxime (C), 10 adult CAPD patients (pts) with peritonitis were trained to start the following treatment procedure: a) sterile collection of dialysate effluent for cultures; b) 4 rapid in-and-out exchanges with antibiotic free dialysate; c) addition of 2 g C and 2 g A to a 2-L exchange for 6-h dwell time (the same dosage was repeated once a day in the overnight exchange); d) routine CAPD exchanges." | 1.28 | Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD). ( Conte, G; Fuiano, G; Nani, E; Sepe, V; Viscione, M, 1989) |
"Ceftazidime, cefuroxime and methicillin proved equally effective in the therapy of experimental Staphylococcus aureus endocarditis in rabbits with a dosing regimen of 40 mg/kg intramuscularly at 8-hourly intervals for three days." | 1.27 | Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits. ( Acred, P; McColm, AA; Ryan, DM, 1984) |
"Cefuroxime was used in 17 patients with clinical, bacteriological and/or laboratory signs of acute septic arthritis in comparison with 10 patients given cloxacillin and ampicillin alone, or in combination." | 1.27 | Cefuroxime in acute septic arthritis. ( Hedström, SA; Lidgren, L; Nilsson-Ehle, I, 1984) |
"Cefuroxime was found to be as effective as cefamandole and considerably less expensive in preventing postoperative wound infections in patients undergoing open-heart surgery." | 1.27 | Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime. ( Arom, KV; Lake, KD; Love, KR; Peterson, CD, 1987) |
"Preceding trauma was found in 27 and/or associated diseases (e." | 1.27 | Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. ( Hedström, SA; Söderquist, B, 1986) |
"Treatment with cefuroxime appears to be a safe and effective therapy for pediatric soft-tissue infections due to H influenzae and S pneumoniae." | 1.27 | Cefuroxime therapy for bacteremic soft-tissue infections in children. ( Barson, WJ; Brady, MT; Hribar, MM; Marcon, MJ; Miller, MA; Pacini, DL; Powell, DA, 1985) |
" The area under the concentration/time curve for ceftazidime in vegetations over a post dosing 6 h period was approximately five times greater than that for cefuroxime and three times that for methicillin." | 1.27 | Penetration of beta-lactam antibiotics into cardiac vegetations, aorta and heart muscle in experimental Staphylococcus aureus endocarditis: comparison of ceftazidime, cefuroxime and methicillin. ( McColm, AA; Ryan, DM, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (24.69) | 18.7374 |
1990's | 13 (16.05) | 18.2507 |
2000's | 20 (24.69) | 29.6817 |
2010's | 22 (27.16) | 24.3611 |
2020's | 6 (7.41) | 2.80 |
Authors | Studies |
---|---|
Tøstesen, SK | 1 |
Hanberg, P | 3 |
Bue, M | 3 |
Thillemann, TM | 1 |
Falstie-Jensen, T | 1 |
Tøttrup, M | 3 |
Knudsen, MB | 1 |
Schmedes, AV | 1 |
Stilling, M | 1 |
Bigseth, RS | 1 |
Sandholdt, H | 1 |
Petersen, A | 1 |
Østergaard, C | 1 |
Benfield, T | 3 |
Thorlacius-Ussing, L | 1 |
Munyemana, JB | 1 |
Gatare, B | 1 |
Kabanyana, P | 1 |
Ivang, A | 1 |
Mbarushimana, D | 1 |
Itangishaka, I | 1 |
Niringiyumukiza, JD | 1 |
Musoni, E | 1 |
Buis, DTP | 1 |
van der Vaart, TW | 1 |
Prins, JM | 1 |
van der Meer, JTM | 1 |
Bonten, MJM | 1 |
Sieswerda, E | 1 |
van Werkhoven, CH | 1 |
Sigaloff, KCE | 1 |
Herpers, BL | 1 |
Jansen, RR | 1 |
Rozemeijer, W | 1 |
Soetekouw, R | 1 |
van Twillert, G | 1 |
Veenstra, J | 1 |
Mussema, A | 1 |
Admasu, D | 1 |
Bawore, S | 1 |
Abdo, R | 1 |
Seid, A | 1 |
Koko, AM | 1 |
Ismail, NJ | 1 |
Lasseini, A | 1 |
Shehu, BB | 1 |
Thønnings, S | 1 |
Jensen, KS | 1 |
Nielsen, NB | 1 |
Skjønnemand, M | 1 |
Hansen, DS | 1 |
Lange, KHW | 1 |
Frimodt-Møller, N | 3 |
Jensen, LK | 2 |
Koch, J | 2 |
Henriksen, NL | 1 |
Søballe, K | 2 |
Jensen, HE | 2 |
Puetzler, J | 1 |
Metsemakers, WJ | 1 |
Arens, D | 1 |
Zeiter, S | 1 |
Kuehl, R | 1 |
Raschke, MJ | 1 |
Richards, RG | 1 |
Moriarty, TF | 1 |
Lui, HK | 1 |
Gao, W | 1 |
Cheung, KC | 1 |
Jin, WB | 1 |
Sun, N | 1 |
Kan, JWY | 1 |
Wong, ILK | 1 |
Chiou, J | 1 |
Lin, D | 1 |
Chan, EWC | 1 |
Leung, YC | 1 |
Chan, TH | 1 |
Chen, S | 1 |
Chan, KF | 1 |
Wong, KY | 1 |
Nissen, JL | 1 |
Skov, R | 2 |
Knudsen, JD | 2 |
Ostergaard, C | 2 |
Schønheyder, HC | 3 |
Rahman, A | 1 |
Hossain, MA | 1 |
Paul, SK | 1 |
Sultana, S | 1 |
Haque, N | 1 |
Kabir, MR | 1 |
Hoque, SM | 1 |
Crane, JK | 1 |
Rasmussen, JB | 1 |
Arpi, M | 1 |
Andersen, C | 1 |
Kahl, BC | 1 |
Olesen, HV | 1 |
Jensen-Fangel, S | 1 |
Nørskov-Lauritsen, N | 1 |
Schweizer, ML | 1 |
Chiang, HY | 1 |
Septimus, E | 1 |
Moody, J | 1 |
Braun, B | 1 |
Hafner, J | 1 |
Ward, MA | 1 |
Hickok, J | 1 |
Perencevich, EN | 1 |
Diekema, DJ | 1 |
Richards, CL | 1 |
Cavanaugh, JE | 1 |
Perlin, JB | 1 |
Herwaldt, LA | 1 |
Burton, C | 1 |
Walls, T | 1 |
Price, N | 1 |
Glasgow, T | 1 |
Walker, C | 1 |
Beasley, S | 1 |
Best, E | 1 |
Aalbæk, B | 1 |
Fuursted, K | 1 |
Capdevila, A | 1 |
Navarro, M | 1 |
Bori, G | 2 |
Tornero, E | 1 |
Camacho, P | 1 |
Bosch, J | 1 |
García, S | 2 |
Mensa, J | 2 |
Soriano, A | 2 |
Rasouli, JJ | 1 |
Kopell, BH | 1 |
Ilhan, G | 1 |
Verit Atmaca, FF | 1 |
Kaya, A | 1 |
Ergin, AH | 1 |
Gökmen Karasu, AF | 1 |
Turfan, M | 1 |
Díez, MR | 1 |
De la Rosa, G | 1 |
Pascual, R | 1 |
Girón, C | 1 |
Arteta, M | 1 |
Francis, IC | 1 |
Roufas, A | 1 |
Figueira, EC | 1 |
Pandya, VB | 1 |
Bhardwaj, G | 1 |
Chui, J | 1 |
Zhao, H | 1 |
Kang, XL | 1 |
Chen, XL | 1 |
Wang, JX | 1 |
Le, Y | 1 |
Shen, ZG | 1 |
Chen, JF | 1 |
Mitsionis, GI | 1 |
Manoudis, GN | 1 |
Lykissas, MG | 1 |
Sionti, I | 1 |
Motsis, E | 1 |
Georgoulis, AD | 1 |
Berisa, AE | 1 |
Nannini, EC | 1 |
Stryjewski, ME | 1 |
Singh, KV | 1 |
Rude, TH | 1 |
Corey, GR | 1 |
Fowler, VG | 1 |
Murray, BE | 1 |
Tyllianakis, ME | 1 |
Karageorgos, ACh | 1 |
Marangos, MN | 1 |
Saridis, AG | 1 |
Lambiris, EE | 1 |
Reiss-Zimmermann, M | 1 |
Hirsch, W | 1 |
Schuster, V | 1 |
Wojan, M | 1 |
Sorge, I | 1 |
Sandal, G | 1 |
Uras, N | 1 |
Akar, M | 1 |
Oguz, SS | 1 |
Erdeve, O | 1 |
Dilmen, U | 1 |
Melendez, J | 1 |
Claxton, A | 1 |
Erskine, K | 1 |
von der Brelie, C | 1 |
Simon, A | 1 |
Gröner, A | 1 |
Molitor, E | 1 |
Simon, M | 1 |
Suleiman, IA | 1 |
Bamiro, BS | 1 |
Tayo, F | 1 |
Espersen, F | 1 |
Greb, C | 1 |
Kalem, T | 1 |
Kälble, T | 1 |
Zvulunov, A | 1 |
Gal, N | 1 |
Segev, Z | 1 |
Bagatur, AE | 1 |
Zorer, G | 1 |
Nørgaard, M | 1 |
Gudmundsdottir, G | 1 |
Larsen, CS | 1 |
Petzsch, M | 1 |
Leber, W | 1 |
Westphal, B | 1 |
Crusius, S | 1 |
Reisinger, EC | 1 |
Cloke, DJ | 1 |
Green, JE | 1 |
Khan, AL | 1 |
Hodgkinson, PD | 1 |
McLean, NR | 1 |
von Eiff, C | 1 |
Friedrich, AW | 1 |
Becker, K | 1 |
Peters, G | 1 |
Gelosa, L | 1 |
Popescu, D | 1 |
Martínez, JA | 1 |
Balasso, V | 1 |
Marco, F | 1 |
Almela, M | 1 |
Byrne, AM | 1 |
Morris, S | 1 |
McCarthy, T | 1 |
Quinlan, W | 1 |
O'byrne, JM | 1 |
García-Alvarez, F | 2 |
Monzón, M | 3 |
Grasa, JM | 1 |
Laclériga, A | 3 |
Amorena, B | 3 |
García-Alvarez, I | 1 |
Navarro-Zorraquino, M | 1 |
Alvarez, FG | 1 |
Garey, KW | 1 |
Lai, D | 1 |
Dao-Tran, TK | 1 |
Gentry, LO | 1 |
Hwang, LY | 1 |
Davis, BR | 1 |
Guerin, M | 1 |
Orazakai, A | 1 |
Cross, KS | 1 |
Beatty, S | 1 |
Mayer, AD | 1 |
Brennan, SS | 1 |
Pickford, IR | 1 |
Evans, M | 1 |
Pollock, AV | 1 |
Keighley, MR | 2 |
Eastwood, D | 1 |
Clements, D | 1 |
Clarke, P | 1 |
Burdon, DW | 2 |
Morris, DL | 1 |
Young, D | 1 |
Morran, CG | 1 |
Thomson, G | 1 |
White, A | 1 |
McNaught, W | 1 |
Smith, DC | 1 |
McArdle, CS | 1 |
McColm, AA | 2 |
Ryan, DM | 2 |
Acred, P | 1 |
Hedström, SA | 2 |
Lidgren, L | 1 |
Nilsson-Ehle, I | 1 |
Trollfors, B | 1 |
Suurkula, M | 1 |
Price, JD | 1 |
Norrby, R | 1 |
Azzoni, P | 1 |
Tydén, G | 1 |
Brattström, C | 1 |
Malmborg, AS | 1 |
Baudin, F | 1 |
Ozier, Y | 1 |
Nord, KD | 1 |
Dore, DD | 1 |
Deeney, VF | 1 |
Armstrong, AL | 1 |
Cundy, PJ | 1 |
Cole, BF | 1 |
Ehrlich, MG | 1 |
Paniara, O | 1 |
Platsouka, E | 1 |
Dimopoulou, H | 1 |
Constantoulaki, S | 1 |
Mauerhan, DR | 1 |
Nelson, CL | 1 |
Smith, DL | 1 |
Fitzgerald, RH | 1 |
Slama, TG | 1 |
Petty, RW | 1 |
Jones, RE | 1 |
Evans, RP | 1 |
Steele, RJ | 1 |
Meyer, DR | 1 |
Kropman, RF | 1 |
de la Fuente, RB | 1 |
Venema, PL | 1 |
van Imhoff, WL | 1 |
Barg, N | 1 |
Gracia, E | 2 |
Leiva, J | 2 |
Oteiza, C | 2 |
Johnson, PA | 1 |
Rodriguez, HP | 1 |
Wazen, JJ | 1 |
Huck, W | 1 |
Shan, M | 1 |
Tosiello, R | 1 |
Heyd, A | 1 |
Echols, RM | 1 |
Yoshii, T | 1 |
Yoshikawa, T | 1 |
Furudoi, S | 1 |
Yoshioka, A | 1 |
Ohtsuka, Y | 1 |
Komori, T | 1 |
Lawson, PA | 1 |
Nikolaitchouk, N | 1 |
Falsen, E | 1 |
Westling, K | 1 |
Collins, MD | 1 |
Kobayashi, Y | 1 |
Morikawa, Y | 1 |
Haruta, T | 1 |
Fujiwara, T | 1 |
Were, AJ | 1 |
Marsden, A | 1 |
Tooth, A | 1 |
Ramsden, R | 1 |
Mistry, CD | 1 |
Gokal, R | 1 |
Wilcox, MH | 1 |
Rice, P | 1 |
Spencer, RC | 1 |
Edwards, WH | 2 |
Kaiser, AB | 1 |
Kernodle, DS | 1 |
Appleby, TC | 1 |
Martin, RS | 1 |
Mulherin, JL | 1 |
Wood, CA | 1 |
Fuiano, G | 1 |
Sepe, V | 1 |
Viscione, M | 1 |
Nani, E | 1 |
Conte, G | 1 |
Hansen-Nord, M | 1 |
Gahrn-Hansen, B | 1 |
Siboni, K | 1 |
Klinger, M | 1 |
Peterson, CD | 1 |
Lake, KD | 1 |
Arom, KV | 1 |
Love, KR | 1 |
van Oeveren, W | 1 |
Dankert, J | 1 |
Wildevuur, W | 1 |
Wildevuur, CR | 1 |
Söderquist, B | 1 |
Claesson, BE | 1 |
Filipsson, S | 1 |
Holmlund, DE | 1 |
Mätzsch, TW | 1 |
Wählby, L | 1 |
Sørensen, TS | 1 |
Barson, WJ | 1 |
Miller, MA | 1 |
Marcon, MJ | 1 |
Hribar, MM | 1 |
Brady, MT | 1 |
Pacini, DL | 1 |
Powell, DA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pilot Randomised Controlled Trial of Penicillin Versus Flucloxacillin for Definitive Treatment of Invasive Penicillin Susceptible Staphylococcus Aureus[NCT03632642] | Phase 4 | 0 participants (Actual) | Interventional | 2019-07-01 | Withdrawn (stopped due to Study never commenced) | ||
Improving Case Selection for Perioperative S. Aureus Transmission Surveillance to Reduce Surgical Site Infections[NCT04299737] | 0 participants (Actual) | Observational | 2020-03-09 | Withdrawn (stopped due to Due to the COVID-19 era, clinical research was interrupted, and this study was terminated.) | |||
An Investigation of Novel Technology to Bring Genomic Analysis to the Patient Bedside to Systematically Track and Report on ESKAPE Bacterial Transmission in Today's Operating Room Environments[NCT03605498] | 83 participants (Actual) | Observational | 2017-09-05 | Completed | |||
Efficacy of Teicoplanin for the Prevention of Surgical Site Infections After Total Hip or Knee Arthroplasty: A Prospective, Open-Label Randomized Study[NCT00719056] | Phase 4 | 616 participants (Actual) | Interventional | 2004-08-31 | Completed | ||
The Effect of Hair Removal on Intraoperative Contamination[NCT04256928] | 200 participants (Anticipated) | Interventional | 2020-02-15 | Not yet recruiting | |||
Prospective, Randomized Study of the Utilization of Antibiotics and Drains in Spinal Surgery[NCT01608854] | 539 participants (Actual) | Observational | 2008-11-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for cefuroxime and Infections, Staphylococcal
Article | Year |
---|---|
Acute hematogenous osteomyelitis of the pelvis in childhood: Diagnostic clues and pitfalls.
Topics: Acute Disease; Anti-Bacterial Agents; Blood; Cefuroxime; Child; Humans; Male; Osteomyelitis; Pelvic | 2003 |
11 trials available for cefuroxime and Infections, Staphylococcal
Article | Year |
---|---|
Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Arth | 2015 |
Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Arth | 2015 |
Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Arth | 2015 |
Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Arth | 2015 |
Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, | 2010 |
Outcome following deep wound contamination in cemented arthroplasty.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replace | 2007 |
The prophylaxis of surgical wound infection: is cefuroxime any better than cephaloridine?
Topics: Abdomen; Aged; Cefuroxime; Cephaloridine; Cephalosporins; Clinical Trials as Topic; Double-Blind Met | 1982 |
Measurement of gastric juice pH should not be used for selecting high risk patients requiring antibiotic prophylaxis in gastric surgery.
Topics: Cefuroxime; Cephalosporins; Female; Gastric Juice; Humans; Hydrogen-Ion Concentration; Klebsiella In | 1982 |
Prospective randomized trial of single dose cefuroxime against mezlocillin in elective gastric surgery.
Topics: Abscess; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Humans; Mezlocillin; Penicillin Resis | 1984 |
Wound sepsis after low risk elective cholecystectomy: the effect of cefuroxime.
Topics: Cefuroxime; Cephalosporins; Cholecystectomy; Clinical Trials as Topic; Double-Blind Method; Female; | 1984 |
Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefazolin; Cefuroxime; Double-Blind Method; Drug Adminis | 1994 |
Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Cefuroxime; Cephalosporins; Double-Blind Method; Female; Fol | 1999 |
Cefuroxime versus cefazolin as prophylaxis in vascular surgery.
Topics: Cefazolin; Cefuroxime; Chi-Square Distribution; Drug Evaluation; Humans; Microbial Sensitivity Tests | 1992 |
Selective cefuroxime prophylaxis following colorectal surgery based on intra-operative dipslide culture.
Topics: Cefuroxime; Cephalosporins; Colon; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Metron | 1986 |
69 other studies available for cefuroxime and Infections, Staphylococcal
Article | Year |
---|---|
Weight-based cefuroxime dosing provides comparable orthopedic target tissue concentrations between weight groups - a microdialysis porcine study.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Weight; Cefuroxime; Drug Administration | 2022 |
Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Cohort Studies; Humans; Methicillin; Piperacil | 2022 |
Antimicrobial Resistance Profile of Bacteria Causing Pediatric Infections at the University Teaching Hospital in Rwanda.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefadroxil; Ceftazid | 2022 |
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ceftriaxone; Cefuroxime; Floxacillin; Humans | 2023 |
BACTERIAL PROFILE, ANTIMICROBIAL RESISTANCE, AND FACTORS ASSOCIATED WITH URINARY TRACT INFECTION AMONG PREGNANT WOMEN AT HOSANNA TOWN HEALTH FACILITIES, CENTRAL ETHIOPIA.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Bacteriuria; Cefuroxime; Cephalexin; Cross-Sectional St | 2023 |
Remarkable recovery in an infant with brain abscesses.
Topics: Anti-Bacterial Agents; Brain Abscess; Ceftriaxone; Cefuroxime; Craniotomy; Drainage; Humans; Hydroce | 2019 |
Cefuroxime pharmacokinetics and pharmacodynamics for intravenous dosage regimens with 750 mg or 1500 mg doses in healthy young volunteers.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Escherichia coli; Escherichia coli Infections; Female; Hea | 2020 |
Suppurative Inflammation and Local Tissue Destruction Reduce the Penetration of Cefuroxime to Infected Bone Implant Cavities.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Inflammation; Osteomyelitis; Prostheses and Implants; Pr | 2017 |
Antibiotic Prophylaxis With Cefuroxime: Influence of Duration on Infection Rate With Staphylococcus aureus in a Contaminated Open Fracture Model.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bone Plates; Cefuroxime; Disease Models, Ani | 2018 |
Boosting the efficacy of anti-MRSA β-lactam antibiotics via an easily accessible, non-cytotoxic and orally bioavailable FtsZ inhibitor.
Topics: Animals; Bacterial Proteins; beta-Lactams; Binding Sites; Cefuroxime; Cytoskeletal Proteins; Drug Sy | 2019 |
Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; | 2013 |
Methicillin-resistant coagulase-negative staphylococci (MRCoNS) by disk diffusion method.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Coagulase; Drug Resistance, Multiple, | 2013 |
Resurgence of penicillin-susceptible Staphylococcus aureus at a hospital in New York State, USA.
Topics: Anti-Bacterial Agents; Bacteremia; Cefuroxime; Dicloxacillin; Female; Humans; Male; Penicillins; Sta | 2014 |
Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Cohort Studies; Dicloxacilli | 2014 |
Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients.
Topics: Administration, Intravenous; Adolescent; Adult; Anti-Bacterial Agents; Cefuroxime; Child; Child, Pre | 2014 |
Paediatric empyema in New Zealand: a tale of two cities.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Cefuro | 2015 |
Effects of Implant-Associated Osteomyelitis on Cefuroxime Bone Pharmacokinetics: Assessment in a Porcine Model.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cefuroxime; Female; Osteomyelitis; Prosthesis-Rela | 2016 |
Incidence and Risk Factors for Infection When Teicoplanin Is Included for Prophylaxis in Patients with Hip Fracture.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Bo | 2016 |
The Adjunctive Use of Vancomycin Powder Appears Safe and May Reduce the Incidence of Surgical-Site Infections After Deep Brain Stimulation Surgery.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Burkholderia cepacia; | 2016 |
Risk factors and microbiology of wound infections following cesarean delivery: Experience of a single institution.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cefuroxime; Cesarean Secti | 2016 |
[Prophylaxis of postoperative endophthalmitis with intracameral cefuroxime: a five years' experience].
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Corynebacterium Infecti | 2009 |
Endophthalmitis following cataract surgery: the sucking corneal wound.
Topics: Anti-Bacterial Agents; Cefuroxime; Cornea; Endophthalmitis; Eye Infections, Bacterial; Humans; Lens | 2009 |
Antibacterial activities of amorphous cefuroxime axetil ultrafine particles prepared by high gravity antisolvent precipitation (HGAP).
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Chemical Precipitation; Drug Compounding; Escherichia co | 2009 |
Pyomyositis in children: early diagnosis and treatment.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Combined Modali | 2009 |
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalexin; Cephalosporins; Cephalothin; Humans; Met | 2010 |
Pyogenic osteomyelitis of the vertebral arch in children.
Topics: Adolescent; Bone Marrow Diseases; Cefuroxime; Child; Clindamycin; Humans; Lumbar Vertebrae; Magnetic | 2010 |
Iliac osteomyelitis in a newborn: a case report.
Topics: Anti-Bacterial Agents; Blood; Cefuroxime; Humans; Ilium; Infant, Newborn; Methicillin; Microbial Sen | 2012 |
MRSA bacteraemia after caesarean section wound infection: when screening is missed and things go wrong.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefuroxime; Cesarean Sec | 2012 |
Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; | 2012 |
Cost effectiveness of three drugs for the treatment of S. aureus infections in Nigeria.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Cost-Benefit Analysis; Gentamicins; Humans; Nigeri | 2012 |
In vitro susceptibility of Staphylococcus aureus towards amoxycillin-clavulanic acid, penicillin-clavulanic acid, dicloxacillin and cefuroxime.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefuroxime; Dicloxacillin; Drug Ther | 2002 |
[Antibiotic induced diarrhea and pseudomembranous colitis].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Clostridioid | 2003 |
Brodie's abscess of the cuboid bone: a case report.
Topics: Abscess; Adult; Anti-Bacterial Agents; Cefuroxime; Female; Humans; Osteomyelitis; Staphylococcal Inf | 2003 |
Staphylococcus aureus meningitis: experience with cefuroxime treatment during a 16 year period in a Danish region.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefuroxime; Child; Child, Preschool; Cross Infection; De | 2003 |
Progressive Staphylococcus lugdunensis endocarditis despite antibiotic treatment.
Topics: Abscess; Aged; Aorta, Thoracic; Aortic Valve; Cefuroxime; Disease Progression; Dose-Response Relatio | 2004 |
Factors influencing the development of wound infection following free-flap reconstruction for intra-oral cancer.
Topics: Adult; Aged; Aged, 80 and over; Cefuroxime; Drug Therapy, Combination; Female; Humans; Male; Metroni | 2004 |
Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Cephalosporins; Fluoroquinolones; Gene | 2005 |
Variations in sensitivity to antibiotics of staphylococci strains isolated from alimentary workers between 1985-1987.
Topics: Amikacin; Anti-Bacterial Agents; Cefazolin; Cefuroxime; Drug Resistance, Bacterial; Food Industry; H | 1989 |
Usefulness of teicoplanin for preventing methicillin-resistant Staphylococcus aureus infections in orthopedic surgery.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carrier State; Cefuroxime; Cohort | 2006 |
Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Chronic Disease; Ciprofloxacin; Disease Models | 2006 |
Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Coagulase; Coronary Artery Bypass; | 2008 |
Endogenous endophthalmitis following ipsilateral carotid endarterectomy.
Topics: Aged; Anti-Bacterial Agents; Blindness; Cefuroxime; Endarterectomy, Carotid; Endophthalmitis; Female | 2008 |
Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits.
Topics: Animals; Ceftazidime; Cefuroxime; Cephalosporins; Endocarditis, Bacterial; Female; Methicillin; Micr | 1984 |
Cefuroxime in acute septic arthritis.
Topics: Acinetobacter Infections; Acute Disease; Arthritis, Infectious; Cefuroxime; Cephalosporins; Drug Eva | 1984 |
Renal function during cefuroxime treatment in patients with pre-existing renal impairment.
Topics: Cefuroxime; Cephaloridine; Cephalosporins; Edetic Acid; Furosemide; Gentamicins; Glomerular Filtrati | 1980 |
[Cefuroxime-tobramycin treatment of bacterial infections in cancer patients].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Cephalosporins; Drug Therapy, Combination; | 1980 |
Early antibiotic treatment in acute necrotising pancreatitis.
Topics: Acute Disease; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Humans; Necrosis; Pancreatitis; St | 1995 |
Early antibiotic treatment in acute necrotising pancreatitis.
Topics: Acute Disease; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Humans | 1995 |
Evaluation of treatment modalities for septic arthritis with histological grading and analysis of levels of uronic acid, neutral protease, and interleukin-1.
Topics: Analysis of Variance; Animals; Arthritis, Infectious; Arthroscopy; Cartilage, Articular; Cefuroxime; | 1995 |
In vitro evaluation of cefodizime, cefuroxime, ceftriaxone against respiratory pathogens.
Topics: Cefotaxime; Ceftriaxone; Cefuroxime; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsie | 1994 |
Nasolacrimal duct obstruction and acute dacryocystitis associated with infectious mononucleosis (Epstein-Barr virus)
Topics: Cefuroxime; Cephalosporins; Child; Dacryocystitis; Drug Therapy, Combination; Erythromycin; Eye Infe | 1993 |
Treatment of corpus cavernosum abscess by aspiration and intravenous antibiotics.
Topics: Abscess; Cefuroxime; Erectile Dysfunction; Humans; Injections, Intravenous; Male; Middle Aged; Papav | 1993 |
Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Clarithromycin; Dise | 1998 |
Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cephalosporins; Male; Microbial Sensitivity Te | 1998 |
Evaluation of oral antimicrobial agent levels in tooth extraction sites.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alveolar Process; Anti-Bacterial A | 2001 |
Actinomyces funkei sp. nov., isolated from human clinical specimens.
Topics: Actinomycetales; Adult; Cefuroxime; DNA, Bacterial; DNA, Ribosomal; Drug Therapy, Combination; Endoc | 2001 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic | 2001 |
[Fundamental and clinical studies on cefuroxime in children (author's transl)].
Topics: Animals; Cefazolin; Cefuroxime; Cephalosporins; Child, Preschool; Empyema; Escherichia coli; Female; | 1979 |
Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients.
Topics: Adult; Aged; Cefuroxime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; P | 1992 |
Biliary stent associated infection.
Topics: Aged; Aged, 80 and over; Cefuroxime; Cholestasis; Endoscopes; Female; Humans; Klebsiella Infections; | 1991 |
Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
Topics: Aztreonam; Cefuroxime; Drug Administration Schedule; Drug Therapy, Combination; Evaluation Studies a | 1989 |
Studies on clinical isolates of coagulase-negative staphylococci resistant to methicillin. Evidence of cross-resistance between methicillin and cephalothin.
Topics: Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Cephalothin; Coagulase; Drug Resistance, Microbia | 1988 |
[Cerebrospinal fluid, brain and abscess permeability of antibiotics].
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain Abscess; Cefurox | 1986 |
Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime.
Topics: Cardiac Surgical Procedures; Cefamandole; Cefuroxime; Cephalosporins; Coronary Artery Bypass; Heart | 1987 |
Prophylactic antibiotic treatment prevents infection after cardiopulmonary bypass: a study in dogs.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Bactericidal Activity; Cardiopulmonary B | 1987 |
Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bursitis; Cefuroxime; Diabetes | 1986 |
Comparative in vitro activity of four beta-lactam antibiotics in surgical wound fluid against staphylococci.
Topics: Anti-Bacterial Agents; Cefuroxime; Cephalothin; Culture Media; Dicloxacillin; Hip Fractures; Humans; | 1985 |
Cefuroxime therapy for bacteremic soft-tissue infections in children.
Topics: beta-Lactamases; Cefuroxime; Cellulitis; Cephalosporins; Child, Preschool; Drug Resistance, Microbia | 1985 |
Penetration of beta-lactam antibiotics into cardiac vegetations, aorta and heart muscle in experimental Staphylococcus aureus endocarditis: comparison of ceftazidime, cefuroxime and methicillin.
Topics: Animals; Anti-Bacterial Agents; Body Fluids; Ceftazidime; Cefuroxime; Endocarditis, Bacterial; Femal | 1985 |